Skip to main content
. 2018 Nov 20;21(11):841–848. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2018.11.06

1.

患者一般资料

Baseline of the patients

PPR group (n=43) CS group (n=58) Test value P
PPR: preoperative pulmonary rehabilitation; CS: conventional scheme; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; MVV: maximum ventilatory volume; PEF: peak expiratory flow; COPD: chronic obstructive pulmonary disease; RUL: right upper lobe; RML: right middle lobe; RLL: right lower lobe; RU-ML: right upper middle lobe; RM-LL: right middle lower lobe; LUL: left upper lobe; LLL: left lower lobe; SC: squamous carcinoma; AC: adenocarcinoma.
Age (Mean±SD, yr) 58.9±8.9 61.1±9.1 t=0.308 0.580
Gender χ2=0.117 0.733
  Male 26 37
  Female 17 21
Pulmonary function
  FEV1 (L) 2.06±0.45 2.16±0.47 t=1.074 0.285
  FVC (L) 3.16±0.68 3.27±0.68 t=0.830 0.409
  PEF (L/s) 4.32±0.90 4.51±0.99 t=0.946 0.346
  MVV (L/min) 86.69±16.56 90.59±15.60 t=1.210 0.229
Severity of COPD χ2=0.117 0.494
  Mild 30 44
  Moderate to severe 13 14
Resection range χ2=3.173 0.787
  RUL 18 27
  RML 2 1
  RLL 8 9
  RU-ML 0 1
  RM-LL 1 0
  LUL 7 11
  LLL 7 9
Pathology χ2=0.218 0.897
  SC 16 19
  AC 25 36
  Other types 2 3
Pathological stage χ2=1.576 0.455
  Stage Ⅰ 21 32
  Stage Ⅱ 11 17
  Stage Ⅲ 11 9
  Stage Ⅳ 0 0